Computerized System Validation Guideline (Japan)
This whitepaper describes the correspondence between the items in the "Computerized System Validation Guideline for Manufacturers of Drug and Quasi-Drugs" and the implementation status of controls compatible with other certifications that Salesforce has already acquired.
Files
Available versions for download
Reporting Start Date | Reporting End Date | Notes | Actions |
---|---|---|---|
2021-11-30 | - | - |
Services covered
Services related to this document